Aligos Therapeutics, Inc.

ALGS

$6.22

+0.16%

N/A+$0.01

Healthcare

Biotechnology

NASDAQ

Active Trading

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for significant unmet medical needs in both viral and ...

Insider Transactions of ALGS

Acquisitions (A)

Since Mar 9, 2026

Disposals (D)

Since Mar 9, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jun 25, 2026	Preston Heather	director	Stock Option (Right to Buy)	A	5,860	$5.50
Jun 25, 2026	Chavez Margarita	director	Stock Option (Right to Buy)	A	5,860	$5.50
Jun 25, 2026	Martell Bridget A	director	Stock Option (Right to Buy)	A	5,860	$5.50
Jun 25, 2026	Scopa James Paul	director	Stock Option (Right to Buy)	A	5,860	$5.50
Jun 25, 2026	Nuechterlein Carole	director	Stock Option (Right to Buy)	A	5,860	$5.50

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

211,245

Total Shares Sold

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

BLATT LAWRENCE

director, officer: President and CEO • 1 txns

Preston Heather

director • 1 txns

Chavez Margarita

director • 1 txns

Martell Bridget A

director • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Jun 25, 2026	Preston Heather	director	Stock Option (Right to Buy)	A	5,860	$5.50	$32,230.00
Jun 25, 2026	Chavez Margarita	director	Stock Option (Right to Buy)	A	5,860	$5.50	$32,230.00
Jun 25, 2026	Martell Bridget A	director	Stock Option (Right to Buy)	A	5,860	$5.50	$32,230.00
Jun 25, 2026	Scopa James Paul	director	Stock Option (Right to Buy)	A	5,860	$5.50	$32,230.00
Jun 25, 2026	Nuechterlein Carole	director	Stock Option (Right to Buy)	A	5,860	$5.50	$32,230.00
Jun 25, 2026	Hirth Peter	director	Stock Option (Right to Buy)	A	5,860	$5.50	$32,230.00
Mar 9, 2026	Symons Julian A.	officer: See Remarks	Stock Option (Right to Buy)	A	23,310	$7.03	$163,869.30
Mar 9, 2026	Aneja Nikhil	officer: Principal Accounting Officer	Stock Option (Right to Buy)	A	9,450	$7.03	$66,433.50
Mar 9, 2026	Calhoun Lesley Ann	officer: See Remarks	Stock Option (Right to Buy)	A	37,485	$7.03	$263,519.55
Mar 9, 2026	BLATT LAWRENCE	director, officer: President and CEO	Stock Option (Right to Buy)	A	105,840	$7.03	$744,055.20

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer